Refractory Chemotherapy-Induced Peripheral Neuropathy
1 clinical trials · Condition
◉ Watch Refractory Chemotherapy-Induced Peripheral Neuropathy
| Record | Firm | Date |
|---|---|---|
| A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Peripheral Neuropathy Induced by Taxane-Based Chemotherapy (NCT07572461) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-05-01 |
Track Refractory Chemotherapy-Induced Peripheral Neuropathy automatically
Every clearance here is in the API, with alerts when new ones post.